Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Q4 2024 National Health Investors Inc Earnings Call

In This Article:

Participants

Dana Hambly; Director of Investor Relations; National Health Investors Inc

D. Eric Mendelsohn; President, Chief Executive Officer, Director; National Health Investors Inc

Kevin Pascoe; Executive Vice President, Chief Investment Officer; National Health Investors Inc

John Spaid; Chief Financial Officer, Executive Vice President, Treasurer; National Health Investors Inc

Richard Anderson; Analyst; Wedbush Securities Inc.

Juan Sanabria; Analyst; BMO Capital Markets

Omotayo Okusanya; Analyst; Deutsche Bank

Austin Wurschmidt; Analyst; KeyBanc Capital Markets Inc.

John Kilichowski; Analyst; Wells Fargo

Farrell Granath; Analyst; BofA Securities, Inc.

Presentation

Operator

Good day everyone and welcome to the National Health Investors fourth-quarter 2024 earnings webcast and conference call.
(Operator Instructions)
It is now my pleasure to turn the floor over to your host, Dana Hambly. Sir, the floor is yours.

Dana Hambly

Thank you and welcome to the National Health Investors conference call to review results for the fourth quarter of 2024.
On the call today are Eric Mendelsohn, President and CEO; Kevin Pascoe, Chief Investment Officer; John Spaid, Chief Financial Officer; and David Travis, Chief Accounting Officer.
The results as well as notice of the accessibility of this conference call were released after the market closed yesterday in a press release that's been covered by the financial media. Any statements in this conference call, which are not historical facts, are forward-looking statements. NHI cautions investors that any forward-looking statements may involve risks or uncertainties and are not guarantees of the future performance. All forward-looking statements represent NHI's judgment as of the date of this conference call. Investors are urged to carefully review various disclosures made by NHI and its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Form 10-K for the year end of December 31, 2024.
Copies of these filings are available on the SEC's website at sec.gov or on NHI's website at nhireit.com. In addition, certain terms used in this call are non-GAAP financial measures, reconciliations of which are provided in NHI's earnings release and related tables and schedules which have been furnished on Form 8-K to the SEC. Listeners are encouraged to review those reconciliations provided in the earnings release together with all other information provided in that release.
I'll now turn the call over to our CEO, Eric Mendelsohn.